# Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.

> **NCT01437969** · — · COMPLETED · sponsor: **Casa Sollievo della Sofferenza IRCCS** · enrollment: 500 (actual)

## Conditions studied

- Liver Disease

## Interventions

- **GENETIC:** genotyping and/or sequencing

## Key facts

- **NCT ID:** NCT01437969
- **Lead sponsor:** Casa Sollievo della Sofferenza IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-09
- **Final completion:** 2022-09
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2023-08-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437969, "Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01437969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*